Please provide your email address to receive an email when new articles are posted on . The FDA’s Pulmonary-Allergy Drug Advisory Committee voted 16-1 in favor of approving the fixed-dose combination ...

Mauli Desai, MD, Allergist & Immunologist, and David Rosenstreich, MD, Professor of Allergy & Immunology, Microbiology & Immunology, and Otorhinolaryngology, for Montefiore Einstein Anyone who’s ever ...

A new trial at Sheffield Children's Hospital will test whether a combined inhaler can better control asthma symptoms and attacks in youngsters. The study, which focuses on children aged six to 11, ...

One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.

The carbon footprint of blue inhalers is being compared to a lengthy car trip in advice released to asthma patients as British doctors are told to switch out the sprays for a more effective treatment.

For many years, the standard treatment for asthma was an inhaler with a medication called albuterol. Only if that wasn’t enough would additional medicines be added. If symptoms became especially bad, ...

I've known I wanted to be a doctor since a young age, and felt compelled to specialize in allergy very early on. As a patient-turned-physician, I know firsthand the impact allergy and asthma ...

Flovent, a popular steroid inhaler used to treat and control asthma symptoms in children and adults, is being discontinued next week as its manufacturer prepares to roll out a generic version of the ...

Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as ...